The latest from Rhevera Medical.

Endologix Rebrands as Rhevera Medical

3-Year DETOUR2 Results Demonstrate Sustained Symptom Relief and Limb Preservation in Complex SFA Disease

Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio

Endologix Announces Appointment of Steve Deitsch to Board of Directors

Endologix Announces that Scott Huennekens Joins Board of Directors